Therefore, 3D model from biopsies of PC patients can be envisaged for identification of neurotrophins/Trk signalling derangements as well as discovery of new drugs specifically targeting this circuit in aggressive PC. This evidence concerns the gene NTRK1 and pachyonychia congenita.